(Q33340972)

25 July 2017

1 reference

title

Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies (English)

1 reference

idiopathic inflammatory myopathy

25 July 2017

0 references

1 reference

1

Chester V Oddis

1 reference

PubMed ID

15760586

25 July 2017

language of work or name

1 reference

1 April 2005

1 reference

Current Rheumatology Reports

25 July 2017

1 reference

25 July 2017

7

1 reference

25 July 2017

2

1 reference

25 July 2017

87-93

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-005-0059-y

25 July 2017

0 references

cites work

A functional index in myositis.

1 reference

12 December 2020

Polymyositis and dermatomyositis (first of two parts)

1 reference

12 December 2020

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies

1 reference

12 December 2020

Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children

1 reference

12 December 2020

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyos

1 reference

12 December 2020

Clinical assessment in adult onset idiopathic inflammatory myopathy

1 reference

12 December 2020

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

1 reference

12 December 2020

International consensus on preliminary definitions of improvement in adult and juvenile myositis.

1 reference

12 December 2020

Defining Clinical Improvement in Adult and Juvenile Myositis.

1 reference

12 December 2020

Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus

1 reference

12 December 2020

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

1 reference

12 December 2020

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

1 reference

12 December 2020

Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire.

1 reference

12 December 2020

Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982.

1 reference

12 December 2020

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups

1 reference

12 December 2020

Simple method for measurement of lower extremity muscle strength

1 reference

12 December 2020

Polymyositis and dermatomyositis (second of two parts)

1 reference

12 December 2020

Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis

1 reference

12 December 2020

10.1007/S11926-005-0059-Y

Identifiers

DOI

1 reference

PubMed ID

15760586

Dimensions Publication ID

25 July 2017

0 references

1 reference

PubMed ID

15760586